Literature DB >> 17445938

Hepatitis C virus: the viral way to fatty liver.

Sophie Clément, Francesco Negro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17445938     DOI： 10.1016/j.jhep.2007.03.005

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  5 in total

1.  Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.

Authors:  Jennifer C Price; Yifei Ma; Rebecca Scherzer; Natalie Korn; Kyle Tillinghast; Marion G Peters; Susan M Noworolski; Phyllis C Tien
Journal:  Hepatology       Date:  2017-02-03       Impact factor: 17.425

2.  Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals.

Authors:  Valrie Martinez; Thi Dieu Ngan Ta; Zahra Mokhtari; Marguerite Guiguet; Patrick Miailhes; Marc-Antoine Valantin; Frderic Charlotte; Philippe Bertheau; Jean-Michel Molina; Christine Katlama; Eric Caumes
Journal:  BMC Res Notes       Date:  2012-07-09

Review 3.  Immunologic, metabolic and genetic factors in hepatitis C virus infection.

Authors:  Nora A Fierro; Karina Gonzalez-Aldaco; Rafael Torres-Valadez; Erika Martinez-Lopez; Sonia Roman; Arturo Panduro
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

4.  Emodin prevents intrahepatic fat accumulation, inflammation and redox status imbalance during diet-induced hepatosteatosis in rats.

Authors:  Anna Alisi; Anna Pastore; Sara Ceccarelli; Nadia Panera; Daniela Gnani; Giovannella Bruscalupi; Mara Massimi; Giulia Tozzi; Fiorella Piemonte; Valerio Nobili
Journal:  Int J Mol Sci       Date:  2012-02-20       Impact factor: 6.208

5.  Bidirectional lipid droplet velocities are controlled by differential binding strengths of HCV core DII protein.

Authors:  Rodney K Lyn; Graham Hope; Allison R Sherratt; John McLauchlan; John Paul Pezacki
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.